Company Filing History:
Years Active: 2017-2022
Title: The Innovative Contributions of Adam Feiler
Introduction
Adam Feiler is a notable inventor based in Hässelby, Sweden. He has made significant contributions to the field of pharmaceuticals and materials science, holding a total of three patents. His work focuses on innovative processes and methods that enhance the delivery and measurement of bioactive compounds.
Latest Patents
One of Adam Feiler's latest patents is a process for manufacturing porous silica particles loaded with at least one bioactive compound. These particles are specifically designed for lung, nasal, sublingual, and/or pharyngeal delivery. The invention ensures that the particles have a mass median aerodynamic diameter (MMAD) between 0.5 and 15 micrometers, with a geometric standard deviation (GSD) of less than 2.5. This advancement is crucial for the effective diagnosis, prevention, and treatment of various local and systemic disorders.
Another significant patent involves a method and apparatus for measuring physico-chemical properties using a nuclear magnetic resonance spectrometer. This patent outlines methods to determine the initial amounts of substances contained within and outside porous materials. It also includes techniques for measuring the release kinetics of substances from these materials and performing chemical reactions in situ within the spectrometer.
Career Highlights
Throughout his career, Adam Feiler has worked with prominent companies such as PepsiCo, Inc. and Nanologica AB. His experience in these organizations has contributed to his expertise in the development of innovative technologies and processes.
Collaborations
Adam has collaborated with notable professionals in his field, including Robert Corkery and Chris Dimelow. These partnerships have further enhanced his research and development efforts.
Conclusion
Adam Feiler's innovative work in the field of pharmaceuticals and materials science demonstrates his commitment to advancing technology for better health outcomes. His patents reflect a deep understanding of the complexities involved in drug delivery and measurement techniques.